Motivations of patients seeking supportive care for cancer from physicians prescribing homeopathic or conventional medicines: results of an observational cross-sectional study

Karine Danno; Aurélie Colas; Gilles Freyer; Jean-Paul Guastalla; Gérard Duru; Eric Musial; Vincent Libourel; Jean-Philippe Fendler; Jean-Louis Masson; Marie-France Bordet

doi:10.1016/j.homp.2016.09.001

Homeopathy, Table of Contents

Homeopathy 2016; 105(04): 289-298
DOI: 10.1016/j.homp.2016.09.001

Original Paper

Motivations of patients seeking supportive care for cancer from physicians prescribing homeopathic or conventional medicines: results of an observational cross-sectional study

Authors

Karine Danno

¹Laboratoires Boiron, Messimy, France
Aurélie Colas

¹Laboratoires Boiron, Messimy, France
Gilles Freyer

²Université de Lyon, HCL, Service d'Oncologie Médicale, CH Lyon-Sud, Pierre-Bénite, France
Jean-Paul Guastalla

³Centre Léon Bérard, Lyon, France
Gérard Duru

⁴Cyklad Group, Lyon, France
Eric Musial

⁵Cabinet médical, Issoire, France
Vincent Libourel

⁶Cabinet médical, Ecully, France
Jean-Philippe Fendler

⁷CH Saint Joseph Saint Luc, Lyon, France
Jean-Louis Masson

¹Laboratoires Boiron, Messimy, France
Marie-France Bordet

¹Laboratoires Boiron, Messimy, France

Subject Editor:

Abstract

Background & aims: The motivations of patients who consult a homeopathic (GP-Ho) or conventional (GP-CM) general practitioner for supportive care during cancer treatment have not been widely studied. We investigated the reasons why cancer patients consult a GP-Ho versus a GP-CM for supportive care and the GPs' motivations for their prescriptions.

Methods: This observational survey was carried out in France between October 2008 and October 2011. GPs across France were randomly selected and asked to recruit four cancer patients each. At inclusion, the sociodemographic and clinical (including psychological) characteristics and medical history of the patients were recorded by the GPs and the patients noted their quality of life (QoL) and anxiety/depression using the Quality of Life Questionnaire-C30 (QLQ-C30) and Hospital Anxiety and Depression Scale (HADS) self-questionnaires. The main motivations of the patients regarding the type of GP consultation and the main reasons for the GPs' prescriptions were recorded.

Results: Six hundred and forty four patients were included in the analysis: 399 consulted a GP-CM (n = 112) and 245 a GP-Ho (n = 73). Patients consulting a GP-Ho were more often female [OR = 1.93; 95%CI: 1.11–3.35; p = 0.02], employed in a professional capacity [OR = 6.57; 95%CI: 1.96–21.99; p = 0.002], have a shorter time since cancer diagnosis [OR = 2.19; 95%CI: 1.24–3.87; p = 0.007], have received targeted anticancer therapy [OR = 3.70; 95%CI: 1.67–8.18; p = 0.001] and have a high QLQ-C30 score for constipation [OR = 1.01; 95%CI: 1.00–1.02; p = 0.001]. Patients mainly consulted a GP-Ho to receive overall care (73.5% vs. 64.9%; p = 0.024) and medicines to prevent anticancer treatment-related side-effects (63.7% vs. 41.4%; p < 0.0001). In contrast, patients consulted a GP-CM to receive psychological care (50.1% vs. 40.8%; p = 0.021) and more information regarding the oncologists' strategic decisions (p < 0.0001). There was a significantly greater prescription of psychotropic drugs by GP-CM (53.7% vs. 22.4%, p < 0.0001).

Conclusions: Patients consulting a GP-Ho or GP-CM had different motivations for seeking supportive care. There was a significantly greater prescription of psychotropic drugs by GP-CM.

Keywords

Cancer - General practice - Cross-sectional survey - Supportive care - Homeopathy - Complementary medicine

Full Text

References

References
1 Mayo Clinic. Tests and Procedures. Complementary and alternative medicine. Available at: http://www.mayoclinic.org/tests-procedures/complementary-alternative-medicine/basics/definition/PRC-20021745 [Last accessed 29.03.16].
2 Schraub S., Eav S., Schott R., Marx E. Psychological study of cancerous patients using complementary and alternative therapies. [Etude psychologique du recours aux médicines parallèles en cancérologie] [Article in French] Psycho-Oncol 2011; 5: 157-167.
3 Simon L., Prebay D., Beretz A. et al. Médecines complémentaires et alternatives suivies par des patients cancéreux en France. Bull Cancer 2007; 94: 483-488.
4 Saghatchian M., Bihan C., Chenailler C., Mazouni C., Dauchy S., Delaloge S. Exploring frontiers: use of complementary and alternative medicine among patients with early-stage breast cancer. Breast 2014; 23: 279-285.
5 Rodrigues M, Wassermann J, Barthelemy P, et al. Utilisation des médecines alternatives et complémentaires par les patients en cancérologie : résultats de l'étude MAC-AERIO. Eurocancer 2010. Compte rendu du XXIIIe congrès, 22 June 2010, Paris; 95–96.
6 Akpunar D., Bebis H., Yavan T. Use of complementary and alternative medicine in patients with gynecologic cancer: a systematic review. Asian Pac J Cancer Prev 2015; 16: 7847-7852.
7 Institut National du Cancer. Le plan cancer 2009–2013. Available at: http://www.e-cancer.fr/Professionnels-de-sante/Parcours-de-soins-des-patients/Parcours-personnalise-du-patient-pendant-et-apres-le-cancer/Experimentation-du-parcours [Last accessed 21.03.16].
8 Ernst E. Complementary and alternative medicine (CAM) and cancer: the kind face of complementary medicine. Int J Surg 2009; 7: 499-500.
9 Krakowski I. Supportive care for people affected by cancer: concept and management. La Revue du Praticien 2006; 56: 1989-1996.
10 Nissen N., Lunde A., Pedersen C.G., Johannessen H. The use of complementary and alternative medicine after the completion of hospital treatment for colorectal cancer: findings from a questionnaire study in Denmark. BMC Complement Altern Med 2014; 14: 388.
11 Molassiotis A., Fernadez-Ortega P., Pud D. et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005; 16: 655-663.
12 Hwang J.H., Kim W.Y., Ahmed M., Choi S., Kim J., Han D.W. The use of complementary and alternative medicine by Korean breast cancer women: is it associated with severity of symptoms?. Evid Based Complement Alternat Med 2015: 182475.
13 Bismark R.S., Chen H., Dy G.K., Gage-Bouchard E.A., Mahoney M.C. Complementary and alternative medicine use among patients with thoracic malignancies. Support Care Cancer 2014; 22: 1857-1866.
14 Helpman L., Ferguson S.E., Mackean M. et al. Complementary and alternative medicine use among women receiving chemotherapy for ovarian cancer in 2 patient populations. Int J Gynecol Cancer 2011; 21: 587-593.
15 Rossi E., Vita A., Baccetti S., Di Stefano M., Voller F., Zanobini A. Complementary and alternative medicine for cancer patients: results of EPAAC survey on integrative oncology centres in Europe. Support Care Cancer 2015; 23: 1795-1806.
16 Frass M., Friehs H., Thallinger C. et al. Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients – a pragmatic randomized controlled trial. Complement Ther Med 2015; 23: 309-317.
17 Rostock M., Naumann J., Guethlin C., Guenther L., Bartsch H.H., Walach H. Classical homeopathy in the treatment of cancer – a prospective observational study of two independent cohorts. BMC Cancer 2011; 11: 19.
18 Gaertner K., Mullner M., Friehs H. et al. Additive homeopathy in cancer patients: retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna. Complement Ther Med 2014; 22: 320-332.
19 Schmitz O. Les points d'articulation entre homéopathie et oncologie conventionnelle. Une enquête ethnographique auprès de praticiens et d'usagers de l'homéopathie. [Connecting Homeopathy and Conventional Oncology. An ethnographic investigation with practitioners and patients in Brussels] Anthropologie et santé. 2011. Available at: https://anthropologiesante.revues.org/701 [Last accessed 05.04.16].
20 Fayers P., Bottomley A. Group EQoL, Unit QoL Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 38 (04) 2002; S125-S133.
21 Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
22 Kelly C.M., Juurlink D.N., Gomes T. et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ 2010; 340: c693.
23 Richardson M.A., Sanders T., Palmer J.L., Greisinger A., Singletary S.E. Complementary/alternative medicine use in a comprehensive cancer centre and the implications for oncology. J Clin Oncol 2000; 18: 2505-2514.
24 Sollner W., Maislinger S., DeVries A., Steixner E., Rumpold G., Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behaviour: a survey. Cancer 2000; 89: 873-880.
25 Guethlin C., Walach H., Naumann J., Bartsch H.H., Rostock M. Characteristics of cancer patients using homeopathy compared with those in conventional care: a cross-sectional study. Ann Oncol 2010; 21: 1094-1099.
26 Weeks L., Balneaves L.G., Paterson C., Verhoef M. Decision-making about complementary and alternative medicine by cancer patients: integrative literature review. Open Med 2014; 8: e54-e66.
27 Thompson E.A., Reilly D. The homeopathic approach to symptom control in the cancer patient: a prospective observational study. Palliat Med 2002; 16: 227-233.
28 Owen D.K., Lewith G., Stephens C.R. Can doctors respond to patients' increasing interest in complementary and alternative medicine?. BMJ 2001; 322: 154-158.
29 Lert F., Grimaldi-Bensouda L., Rouillon F. et al. Characteristics of patients consulting their regular primary care physician according to their prescribing preferences for homeopathy and complementary medicine. Homeopathy 2014; 103: 51-57.